rapid quantitation of aav capsids in bioprocess development for gene therapy using octet®️ bli
Published 1 year ago • 705 plays • Length 3:01Download video MP4
Download video MP3
Similar videos
-
47:14
analytical ultracentrifugation for characterization of aav gene delivery vectors
-
54:14
strategies for accurate, easy and fast quantitation of aav serotypes
-
31:10
the impact of rapid virus quantification in the development and manufacture of advanced therapies
-
4:42
harnessing aav for gene therapy: from cell lysis to pure aav with advanced filtration techniques
-
58:30
aav vector shedding assay—best practices in clinical gene therapy method development
-
56:19
cost efficient manufacturing of purer aav gene therapy vectors
-
2:51
how aav gene transfer works - expert audience
-
56:31
robust manufacturing of purer aav gene therapy vectors
-
43:52
discovering the next generation aav vector- capsid engineering & expression cassette optimization
-
9:32
evaluation of pilot protocal for detecting infant hyperopia
-
54:19
aav-mediated gene therapy approach: ovid therapeutics
-
34:29
development of an automated aav8 capsid titer assay on gyrolab® xpand immunoassay platform
-
3:05
octet® rh16 and rh96 | high throughput monitoring of binding of proteins and other biomolecules
-
1:29
aav capsid engineering
-
2:01
protein chips for antigen-specific antibody responses | protocol preview
-
2:01
hk autophosphorylation quantification by nitrocellulose binding assay | protocol preview
-
2:01
alzheimer's disease gene susceptibility assessment by rc1 rflp pcr | protocol preview
-
0:55
the fast track to ind: 4cell® cho platform